About 135 million people globally have low vision; this is the term used to describe significant visual impairment that can’t be remedied with eye glasses or surgery. Low vision not only means a loss of sight but it also impacts how a person experiences the world around them. It reduces their independence and the ability to do many of the activities they once enjoyed.
There are many low vision aids, designed to help people maximize their existing vision, offering only basic functionality. Due to the limitations of these existing tools they are unable to effectively remedy the challenges inherent with low vision and often present tradeoffs that encumber the low vision user. Since these rudimentary solutions do little more than magnify, which limits the field of vision, many clinicians are left frustrated with the lack of life-restoring options they can offer their patients.
Through proprietary software which adapts to the user’s visual deficit, environment and daily habits, those with low vision, particular those with age-related macular degeneration, may now have a reason to look up and smile.
Eyedaptic’s powerful suite of software solutions can be deployed across numerous Augmented Reality (AR) platforms and at the same time successfully optimize a person’s field of vision and improve quality of life. Eyedaptic’s embedded simulated natural vision software may just be the answer.
Jay Cormier, Founder and CEO of Eyedaptic, will share how a special Augmented Reality (AR) device with embedded simulated natural vision software provides an impactful visual aid solution for those with AMD and other retinal disorders. This solution will be presented at the upcoming MedTech Strategist Investor Conference at the Hyatt Regency San Francisco Airport on Tuesday November 27th.
In this presentation, Jay will share case studies showing how Eyedaptic’s visual aid can serve as a practical replacement for low vision devices. Eyedaptic’s proprietary vision ‘Portal’ optimizes the user’s remaining field of vision. Validated in continuous user meetings and clinical trials, this new visual aid tool gives users a new lease on life and a renewed sense of independence.
About MedTech Strategist Investor Conference:
MedTech Strategist Investor conferences help innovative start-up companies meet quality contacts for an investment or exit. The annual Innovation Summit San Francisco is recognized as one of the top medical technology investment forums on the west coast and brings together an exclusive community of leading experts, innovators, and key decision-makers to discuss the critical challenges facing the ever-evolving global medical device community.
Eyedaptic is a privately held company that develops visual aid software, enabled by augmented reality hardware, for macular degeneration and other retinal diseases. The proprietary Simulated Natural Vision software goes beyond magnification to enable a fuller field of vision, for those suffering from central vision disorders such as AMD (age-related macular degeneration), to revitalize their quality of life.